UCLA begins study on role of diet and fish/soy supplements in reducing breast cancer.
This article was originally published in The Tan Sheet
Executive Summary
UCLA STUDY ON ROLE OF DIET, FISH/SOY SUPPLEMENTS IN REDUCING BREAST CANCER has been initiated by John Glaspy, MD, medical director of the University of California at Los Angeles Oncology Center. Glaspy is conducting the study under the auspices of the newly established UCLA Breast Cancer Nutrition Program, which he directs. The role of a low-fat diet, which includes fish oil and soy supplements, on metastatic breast cancer will be evaluated in the trial.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC